Project Hope is PIB Group’s partnership and fundraising programme with Alzheimer’s Society. Together, we’re aiming to raise £1m to help change the landscape of dementia and other diseases of the brain.
Thanks to the incredible efforts of colleagues across PIB, our industry partners and the PIB Community Trust, we have already raised over £900,000. Now we’re asking everyone to get involved in the final stretch and help us make it to a million.
Our £1m target will help to:
- Fund the first ever UK‑wide Dementia Research Nurses network, bringing research opportunities to more people, wherever they live;
- Support the Dementia Support Line, providing expert advice and emotional support to people affected by dementia; and
- Back a five‑year research fellowship focused on detecting the early signs of dementia and other diseases of the brain.
- Every donation, whatever the size, brings us closer to our £1m goal and will make a real difference for people living with dementia and those who care for them.
Thank you for supporting Project Hope.
Can you help?
To help us achieve our target, we have extended our appeal across the company https://www.justgiving.com/team/pibgroup.
We have introduced a range of activities that we hope will encourage colleagues to get involved. Friends and family and colleagues are all very welcome to join in and help us meet the challenge while having fun at the same time.
Every penny counts and donations of all sizes are hugely appreciated – both by PIB and by our friends at Alzheimer’s Society.
To add further encouragement the PIB Community Trust will be offering match funding up to a total limit of £50,000 in 2025 towards the fundraising efforts of colleagues across PIB Group.
Project Hope podcast
This podcast, hosted by Group Chief Executive Officer Brendan McManus, explores Dr Henstridge's personal and professional journey into brain disease research, particularly dementia and Alzheimer’s, which was inspired by his own family experiences.
In the podcast, Dr Henstridge expresses optimism that, within five to ten years, ongoing research will yield more effective and targeted treatments.